TrademarkOpen
Search / United States / 88824428

Heads up: we show every live trademark, plus inactive ones from the last 5 years, in the United States, Singapore, Canada, Australia and France. India is looked up live when you search, so it is not a saved copy of every mark, and it can be busy some days. Data is only as fresh as each country publishes it, and some countries aren’t included yet, so a brand can be registered even if it doesn’t show here. Always check the official record before you use a name. This is not legal advice.

🇺🇸 United States · Trademark

E

Registered
Used for: Pharmaceuticals for the treatment of neurodegenerative and mitochondrial diseases and disorders; pharmaceuticals for…
Show more

Pharmaceuticals for the treatment of neurodegenerative and mitochondrial diseases and disorders; pharmaceuticals for the treatment of diseases and disorders that affect movement; steroids

Class 5 – Pharmaceuticals & supplements

Status timeline

  1. 10 Mar 2020
    Application filed
    New Application Entered
  2. 27 May 2020
    Assigned to an examining attorney
    Assigned To Examiner
  3. 28 May 2020
    Approved for publication
    Approved For Pub - Principal Register
  4. 7 Jul 2020
    Published for opposition
    Published For Opposition
  5. 1 Sep 2020
    Notice of allowance issued — statement of use required
    Noa Mailed - Sou Required From Applicant
  6. 24 Feb 2021
    Statement of use filed
    Teas Statement Of Use Received
  7. 12 Mar 2021
    Statement-of-use extension 1 granted
    Sou Extension 1 Granted
  8. 2 Apr 2021
    Statement of use accepted
    Allowed Principal Register - Sou Accepted
  9. 3 Apr 2021
    Statement of use accepted
    Notice Of Acceptance Of Statement Of Use E-Mailed
  10. 11 May 2021
    Registered on the Principal Register
    Registered-Principal Register
All 28 events
2026-05-11Rem1
2025-11-13Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
2025-11-13Attorney/Dom.rep.revoked And/Or Appointed
2025-11-13Teas Change Of Correspondence Received
2023-12-20Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
2023-12-20Attorney/Dom.rep.revoked And/Or Appointed
2023-12-20Teas Change Of Correspondence Received
2023-12-20Teas Withdrawal Of Attorney Received-Firm Retains
2021-05-11Registered-Principal Register
2021-04-03Notice Of Acceptance Of Statement Of Use E-Mailed
2021-04-02Allowed Principal Register - Sou Accepted
2021-03-13Notice Of Approval Of Extension Request E-Mailed
2021-03-12Case Assigned To Intent To Use Paralegal
2021-03-12Sou Extension 1 Granted
2021-03-12Statement Of Use Processing Complete
2021-02-24Teas Statement Of Use Received
2021-02-24Sou Teas Extension Received
2021-02-24Sou Extension 1 Filed
2021-02-24Use Amendment Filed
2020-09-01Noa Mailed - Sou Required From Applicant
2020-07-07Published For Opposition
2020-07-07Official Gazette Publication Confirmation E-Mailed
2020-06-17Notification Of Notice Of Publication E-Mailed
2020-05-28Approved For Pub - Principal Register
2020-05-27Assigned To Examiner
2020-03-13Notice Of Design Search Code E-Mailed
2020-03-12New Application Office Supplied Data Entered
2020-03-10New Application Entered

Goods & services by class

Class 5 Pharmaceuticals & supplements

Pharmaceuticals for the treatment of neurodegenerative and mitochondrial diseases and disorders; pharmaceuticals for the treatment of diseases and disorders that affect movement; steroids

First use anywhere 31 Aug 2020 · First use in commerce 31 Aug 2020

Owner details

See the official record for contact details. View official record →

Source & freshness

Source: the official United States trademark register. This record was last updated on 12 May 2026; the index was built on 20 Nov 2026 and covers data through 31 Aug 2026. View official record → If the two differ, the official record is correct.